Literature DB >> 20514604

Body composition after endogenous (Cushing's syndrome) and exogenous (rheumatoid arthritis) exposure to glucocorticoids.

E Resmini1, C Farkas, B Murillo, M J Barahona, A Santos, M A Martínez-Momblán, O Roig, J Ybarra, C Geli, S M Webb.   

Abstract

Exposure to chronic glucocorticoid (GC) excess determines changes in body composition. The aim of the study was to compare body composition in women exposed to endogenous hypercortisolism (Cushing's syndrome, CS), exogenous glucocorticoid treatment (rheumatoid arthritis, RA) and controls. Fifty-one CS women, 26 RA women treated with low-dose prednisone (5 mg/day or 10 mg/2 days), and 78 female controls were included. Fourteen CS patients were hypercortisolemic, 37 in remission (10 required hydrocortisone substitution after surgery). Body composition parameters were measured by dual-energy X-ray absorptiometry scanning (DEXA). RA patients had a greater waist-hip ratio (WHR) (p<0.01), less lean body mass (LBM) (p<0.01), and lumbar bone mineral density (BMD) (p<0.01) than controls. CS patients, globally and those with cured disease, had more total fat (both percentage and kg) and trunk fat percentage, and less whole body-BMD than RA patients (p<0.05, p<0.01, p<0.05, respectively). Active CS patients had less whole body-BMD and more LBM than RA patients (p<0.05, p=0.01, respectively). Cured CS patients not taking hydrocortisone had more total fat [both percentage (p<0.05) and kg (p<0.05)], trunk fat percentage (p<0.05), lumbar BMD (p<0.01) than RA patients. Cured CS patients requiring hydrocortisone only differed from RA patients by smaller WHR (p<0.01). All the differences in BMD disappeared when the data were reanalyzed including only the estrogen-deficient groups. Hypercortisoliof CS determines an irreversible increase in body fat, greater than in RA. Endogenous and exogenous exposure to GC negatively affects body composition by increasing the WHR. There appears to be no additional effect on BMD in estrogen-deficient women. (c) Georg Thieme Verlag KG Stuttgart . New York.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20514604     DOI: 10.1055/s-0030-1255032

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  7 in total

1.  A measure of glucocorticoid load provided by DNA methylation of Fkbp5 in mice.

Authors:  Richard S Lee; Kellie L K Tamashiro; Xiaoju Yang; Ryan H Purcell; Yuqing Huo; Michael Rongione; James B Potash; Gary S Wand
Journal:  Psychopharmacology (Berl)       Date:  2011-04-21       Impact factor: 4.530

2.  Body composition of rheumatoid arthritis patients in the City of Cape Town, South Africa.

Authors:  L A Lombard; L M du Plessis; J Visser
Journal:  Clin Rheumatol       Date:  2013-11-07       Impact factor: 2.980

3.  Ultrasound-based detection of glucocorticoid-induced impairments of muscle mass and structure in Cushing's disease.

Authors:  M A Minetto; C Caresio; M Salvi; V D'Angelo; N E Gorji; F Molinari; G Arnaldi; S Kesari; E Arvat
Journal:  J Endocrinol Invest       Date:  2018-11-15       Impact factor: 4.256

4.  An unfavorable body composition is common in early arthritis patients: A case control study.

Authors:  Samina A Turk; Dirkjan van Schaardenburg; Maarten Boers; Sylvia de Boer; Cindy Fokker; Willem F Lems; Michael T Nurmohamed
Journal:  PLoS One       Date:  2018-03-22       Impact factor: 3.240

Review 5.  Body composition in patients with rheumatoid arthritis: a narrative literature review.

Authors:  Jean-Guillaume Letarouilly; René-Marc Flipo; Bernard Cortet; Anne Tournadre; Julien Paccou
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-06-21       Impact factor: 5.346

6.  Both transient and continuous corticosterone excess inhibit atherosclerotic plaque formation in APOE*3-leiden.CETP mice.

Authors:  Hanna E Auvinen; Yanan Wang; Hans Princen; Johannes A Romijn; Louis M Havekes; Johannes W A Smit; Onno C Meijer; Nienke R Biermasz; Patrick C N Rensen; Alberto M Pereira
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

7.  Dexamethasone reduces energy expenditure and increases susceptibility to diet-induced obesity in mice.

Authors:  Raffaella Poggioli; Cintia B Ueta; Rafael Arrojo E Drigo; Melany Castillo; Tatiana L Fonseca; Antonio C Bianco
Journal:  Obesity (Silver Spring)       Date:  2013-09       Impact factor: 5.002

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.